While some mutations were common to most of these clones (Pten deletion, Cyclin D–Cdk6 overexpression, and Ikaros splicing changes), other mutations arising later in tumor evolution (by 20 wk after birth) produced dominant clones of T cells contributing to these lymphomas at later times. Here, CDK6 is linked to neoplasm.